Search results for “Interstitial lung disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 450 patents, we discovered top 111 key players by total patent application. Boehringer Ingelheim International GmbH, Vicore Pharma AB, RespiVert Ltd. are dominant in this area. They take 20.44% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 35
Vicore Pharma AB
Sweden
Patent: 35
RespiVert Ltd.
Buckinghamshire, United Kingdom
Patent: 22
Galapagos NV
Belgium
Patent: 21
United Therapeutics Corp.
United States
Patent: 19
Gilead Sciences, Inc.
California, United States
Patent: 17
Maxygen Holdings Ltd.
Cayman Islands
Patent: 13
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
United Kingdom
Patent: 12
Kureha Corp.
Hokkaido, Japan
Patent: 11
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 11
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 242 patents applied in the last 5 years. We discover 76 most active companies in this area. The fast-growing Vicore Pharma AB, Boehringer Ingelheim International GmbH, Gilead Sciences, Inc. take 30.17% of patent filing during this period.
Vicore Pharma AB
Sweden
Patent: 35
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 22
Gilead Sciences, Inc.
California, United States
Patent: 16
INIM Pharma AB
Sweden
Patent: 9
Minoryx Therapeutics SL
Spain
Patent: 8
IMAGENE Co., Ltd.
South Korea
Patent: 7
United Therapeutics Corp.
United States
Patent: 6
PharmaIN Corp.
Washington, United States
Patent: 6
RespiVert Ltd.
Buckinghamshire, United Kingdom
Patent: 5
China-Japan Friendship Hospital
Beijing Shi, China
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 242 patents in last 5 years, we discover 63 new entrants. Vicore Pharma AB, INIM Pharma AB, Minoryx Therapeutics SL are the most active new entrants in this area.
Vicore Pharma AB
Sweden
Patent: 35
INIM Pharma AB
Sweden
Patent: 9
Minoryx Therapeutics SL
Spain
Patent: 8
IMAGENE Co., Ltd.
South Korea
Patent: 7
PharmaIN Corp.
Washington, United States
Patent: 6
China-Japan Friendship Hospital
Beijing Shi, China
Patent: 4
North Carolina State University
North Carolina, United States
Patent: 4
Acceleron Pharma, Inc.
Massachusetts, United States
Patent: 4
Shanghai Yuanxi Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 4
Insmed, Inc.
New Jersey, United States
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 104 patents, we discovered top 26 universities and scientific research institutions by total patent application. The Johns Hopkins University, Yale University, Kagoshima University are dominant in this area. They take 25.96% of the total patent filing.
The Johns Hopkins University
United States
Patent: 12
Yale University
Connecticut, United States
Patent: 9
Kagoshima University
Kagoshima-ken, Japan
Patent: 6
Kyushu University
Fukuoka-ken, Japan
Patent: 5
North Carolina State University
North Carolina, United States
Patent: 4
Université François-Rabelais de Tours
France
Patent: 3
The University of Chicago
Illinois, United States
Patent: 2
Yokohama City University
Kanagawa-ken, Japan
Patent: 2
Kharkiv National Medical University
Ukraine
Patent: 2
Regents of the University of Colorado
Colorado, United States
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: